GlassScriptPhysician profile
Keith Michael Stevens
NPI 1578588679
$752.32
in general payments reported to CMS, 2019-2025
14 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.29 · 2020: $19.61 · 2021: $144 · 2022: $61.48 · 2023: $150 · 2024: $81.92 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $156.71 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Intuitive Surgical, INC. | $143.75 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.52 | 2023 | Glassia |
| Insmed, INC. | $60.15 | 2025 | Arikayce, Brinsupri |
| Sunovion Pharmaceuticals INC. | $54.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $50.38 | 2022-2024 | Fasenra |
| Baxter Healthcare | $36.58 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $34.07 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Shire North American Group INC | $32.14 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $30.44 | 2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.04 | 2023 | Stiolto Respimat, Spiriva Respimat |
| E.R. Squibb & Sons, L.L.C. | $20.79 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $19.61 | 2020 | |
| Electromed, INC. | $15.09 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.